Tivicay PD (dolutegravir) Disease Interactions
There are 3 disease interactions with Tivicay PD (dolutegravir):
Dolutegravir (applies to Tivicay PD) hemodialysis
Moderate Potential Hazard, Moderate plausibility.
Dolutegravir has not been studied in patients on dialysis, so caution is recommended if used in these patients.
Dolutegravir (applies to Tivicay PD) hepatitis
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infectious Hepatitis
Patients with underlying hepatitis B or C may be at increased risk for worsening or development of transaminase elevations with the use of dolutegravir. In some cases there was hepatitis B reactivation particularly in a setting where anti- hepatitis treatment was withdrawn. Appropriate laboratory testing prior to initiating treatment and monitoring for hepatotoxicity during therapy is recommended in patients with underlying hepatitis B or C.
Dolutegravir (applies to Tivicay PD) liver impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
The effect of severe hepatic impairment (Child - Pugh C) on the pharmacokinetics of dolutegravir has not been studied, therefore dolutegravir is not recommended for use on these patients. No dosage adjustment is needed for patients with mild or moderate hepatic impairment.
Tivicay PD (dolutegravir) drug interactions
There are 153 drug interactions with Tivicay PD (dolutegravir)
Tivicay PD (dolutegravir) alcohol/food interactions
There are 2 alcohol/food interactions with Tivicay PD (dolutegravir)
More about Tivicay PD (dolutegravir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: integrase strand transfer inhibitor
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.